Search results
Results From The WOW.Com Content Network
In February 2015, Labcorp acquired Covance for $6.1 billion in cash and stock. [37] [38] In 2016, the company entered into a strategic alliance with Global Specimen Solutions, in which the company offered GSS products GlobalCODE and snapTRACK to its clients. [39] In December 2017, Covance acquired the company. [40]
In December 2014, Labcorp acquired Bode Technology Group, a provider of forensic DNA analysis, DNA collection products, and relationship testing and the largest DNA forensic testing company in the U.S., from SolutionPoint International. [49] [50] [51] In February 2015, Labcorp acquired Covance for $6.1 billion. [52] [53]
On August 31, 2017, Labcorp acquired global life sciences business, Chiltern, as part of its drug development services with Covance. The Chiltern acquisition included a subsidiary of Endpoint Clinical Inc and their interactive response technology (IRT) systems. In 2018, Labcorp sold the Covance Food Solutions business to Eurofins for $670 million.
LabCorp's (LH) Covance arm grows on strategic acquisitions including MI Bioresearch. Skip to main content. Sign in. Mail. 24/7 Help. For premium support please call: 800-290-4726 more ...
Laboratory Corp of America Holdings (NYSE: LH) is in talks to combine some of its assets with Syneos Health Inc (NASDAQ: SYNH), reports Bloomberg citing people with knowledge of the matter. The ...
LabCorp (LH) expands service portfolio through Covance's data management portal. Skip to main content. Sign in. Mail. 24/7 Help. For premium support please call: 800-290-4726 ...
April 1999: Covance (now Fortea) announced it would acquire Parexel for $612.7 million in stock; [20] however, the agreement was terminated two months later. [21] September 1999: Parexel acquires CEMAF S.A., a Phase I clinical research and bioanalytical laboratory located in Poitiers, France for an initial cash payment of approximately $3.0 ...
For premium support please call: 800-290-4726 more ways to reach us